The drugs are classified as High Potent if
its Occupational Exposure Limit (OELs) ≤ 10µg/m3.The HPAPI global market is
progressively increasing in terms of revenue and the rise in demand for
outsourcing these intermediates, manufacturing is driven by expansion of
oncology sector, which is the fastest among overall pharmaceutical sector.
The global HPAPI market is expected to
reach $27,293.4 million by 2023. HPAPI market is mainly classified by customer
base, by business type, by molecule type and Applications. The global HPAPI
market is broadly classified as Innovative HPAPI and Generic HPAPI based on
customer base. Based on business type, the market is classified into Captive
HPAPI & Merchant HPAPI. HPAPI market is segmented on the basis of molecule
type as Synthetic HPAPI and Biotech HPAPI. HPAPI market application segment is
classified into Oncology, Cardiovascular, Central Nervous System, Hormonal, Glaucoma,
Infectious, metabolic, Inflammation and other therapeutic applications.
Among Innovative & generic HPAPI,
Innovative HPAPI occupies the major share in 2016 and generic HPAPIs expected
to grow at a highest CAGR from 2016 to 2023.
Increasing incidence of chronic and age
related diseases, rapid growth in oncology market, growing demand for Antibody
Drug Conjugates (ADC), technological advancements in HPAPI market, growing CMOs
are some of the factors which are driving the market. Requirement of large investments,
stringent safety and handling specifications associated with production of
HPAPI, stringent regulations are the factors hindering the market.
North America accounts for the highest
market share in 2016 and followed by Europe. However, Asian countries
especially China and India are the fastest growing regions with its growing
demand for HPAPIs.
Major players in HPAPI market include
Alkermes plc (Ireland),Cambrex Corporation (U.S.),Dishman group (India), Dr.
Reddy’s Laboratories (India), Lonza Group (Switzerland), Novasep (U.S.),
Patheon N.V.( Netherland)(ThermoFisher Scientific), Pfizer (U.S.), Merck KGaA
(Germany) and Teva Pharmaceutical Industries (Israel).
The
report provides an in depth market analysis of the above mentioned segments
across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World
Spanning over 226 pages “High
Potency Active Pharmaceutical Ingredients (HPAPI) Global Market - Forecast To
2023” report
covers Executive Summary, Introduction, Market Analysis, Hpapi Global Market,
By Customer Base, Hpapi Global Market, By Business Type, Hpapi Global Market,
By Molecule Type, Hpapi Global Market, By Applications, Regional Market
Analysis, Competitive Landscape, Major Companies. This Report Covered 127
Companies Few Are - Alkermes Plc, Cambrex Corporation, Dishman Group, Dr.
Reddy’s Laboratories, Lonza Group, Novasep, Patheon N.V., Pfizer Inc., Merck
Kgaa, Teva Pharmaceutical Industries.
Please visit this link for more details: http://mrr.cm/U5E
Find all Pharma
and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.